Xiaona Fan
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Noninvasive detection and differentiation of gastric malignancy using cell-free DNA biomarkers.
Journal: Journal of advanced research
Published: May 22, 2025
TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 25, 2024
Clinical Manifestation, Risk Factors, and Immune Checkpoint Inhibitor Rechallenge of Checkpoint Inhibitor-Associated Pneumonitis in Patients With Lung Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 08, 2024
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.
Journal: The oncologist
Published: January 18, 2024
VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
Journal: Cell communication and signaling : CCS
Published: October 15, 2023
Effects of magnetic resonance imaging (MRI)-detected extramural vascular invasion (mrEMVI) and tumor deposits (TDs) on distant metastasis and long-term survival after surgery for stage III rectal cancer: a retrospective study grouped based on the relationship between the bottom of the tumor and peritoneal reflection.
Journal: Journal of gastrointestinal oncology
Published: February 17, 2023
Prediction scores of postoperative liver metastasis and long-term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19-9 level, and lymph node metastasis rate.
Journal: Cancer medicine
Published: February 19, 2022
Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection.
Journal: Frontiers in oncology
Published: March 23, 2021
Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti-PD-1 Therapy.
Journal: Frontiers in cell and developmental biology
Published: December 06, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026